BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 16, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 24, 2001
View Archived Issues
Delta Pharmaceuticals reports name change
Read More
Pharmacological profile of Ono-6818, an orally active HNE inhibitor, discussed at ATS meeting
Read More
Tripep provides update on lead drug candidate GPG
Read More
Viozan produces rapid and sustained activation of D2 receptors and beta2-adrenoceptors
Read More
Prostanoid receptor agonist protects against warm ischemia-reperfusion injury in rat kidneys
Read More
Company Profile: Apovia
Read More
Bimosiamose blocks kidney allograft rejection and is synergistic with other agents
Read More
Sepracor seeks FDA approval to evaluate new anxiolytic in humans
Read More
Ergo Science looking to sell or license Ergoset property rights
Read More
Posttranscriptional TNF inhibitor advances towards clinical trials for IBD
Read More
Femara approved in Canada as first-line treatment for advanced breast cancer
Read More
ID Biomedical begins clinical evaluation of intranasal influenza vaccine
Read More
Curcumin may have additional potential in acute pancreatitis
Read More
Hybridon completes sale of remaining shares in MethylGene
Read More
Development and commercialization rights to ISIS-113715 licensed by Merck
Read More
Dual antiinflammatory and antiproliferative effects reported for sPLA2 inhibitor
Read More
Dynavax initiates two new phase II/III trials for ragweed allergy treatment
Read More
Company Profile: EluSys Therapeutics
Read More
First patent for oral gene delivery owned by Genteric
Read More
Atherosclerosis inhibited by anti-MCP-1 gene therapy
Read More
Peptides based on Mcep sequence and use in tuberculosis vaccines
Read More
Ergoline derivatives synthesized at Novartis useful in depression, anxiety, etc.
Read More
Orally active, nontoxic antimicrobial agents in the Aventis pipeline
Read More
Merck describes new integrin receptor antagonists and therapeutic use thereof
Read More
Kissei researchers identify potential new treatments for diabetes and related disorders
Read More
Erythromycin derivatives with potent activity against staphylococci and streptococci
Read More
New serotonergic agents from BASF covered by U.S. patent
Read More